ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA

Glioblastoma (GBM) is the most common and aggressive primary brain cancer. Current standard-of-care includes surgery followed by concurrent therapy with radiation and temozolomide (TMZ) and maintenance TMZ. Almost all GBM patients experience recurrent/progressive disease, and median survival after r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: O’Brien, Barbara, de Groot, John, Kamiya-Matsuoka, Carlos, Weathers, Shiao-Pei, Bacha, Jeffrey, Brown, Dennis, Steino, Anne, Langlands, John, Schwartz, Richard, Kanekal, Sarath, Lopez, Lorena, Penas-Prado, Marta
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.060
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items